Other infective otitis externa

H8_EXT_INFNAS

otitis externa: Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H60.3 Cause of death: ICD-10 — H60.3 2 out of 7 registries used, show all original rules.	2333
4. Check minimum number of events None	2333
5. Include endpoints None	2333
6. Filter based on genotype QC (FinnGen only)	2333

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H60
Name in latin: Alia otitis externa infectiosa

NAME	H8_EXT_INFNAS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H603
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H603
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infective otitis externa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16526	8526	7935
Only index persons	15476	8098	7378
Unadjusted period prevalence (%)
Whole population	0.23	0.24	0.22
Only index persons	0.29	0.30	0.28
Median age at first event (years)
Whole population	46.95	45.50	48.53
Only index persons	47.01	45.65	48.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2333	1303	1030
Unadjusted period prevalence (%)	0.45	0.44	0.45
Median age at first event (years)	52.78	48.38	58.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2110: Matched controls
21100

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H60.9

ICD-10 Finland

Otitis externa, unspecified

20.2

323.0

682

487

H60.3

ICD-10 Finland

Other infective otitis externa

+∞

323.0

2110

H60.8

ICD-10 Finland

Other otitis externa

56.8

323.0

413

H60

ICD-10 Finland

Otitis externa

9.6

153.4

333

403

H66.0

ICD-10 Finland

Acute suppurative otitis media

7.1

145.7

389

651

UDC00

NOMESCO Finland

Ear microscopy

6.8

142.0

393

690

Z01.1

ICD-10 Finland

Examination of ears and hearing

4.4

121.1

514

1451

H01

ICPC

Ear pain/earache

4.8

121.1

461

1167

H66.9

ICD-10 Finland

Otitis media, unspecified

6.7

116.3

322

556

H61.2

ICD-10 Finland

Impacted cerumen

8.6

116.0

267

350

H70

ICPC

Otitis externa

15.7

115.3

194

135

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

40.0

95.6

121

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

9.2

95.2

208

247

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

14.7

92.9

160

117

S02CA02

ATC

flumetasone and antiinfectives; otic

6.2

92.9

267

478

DFF00

NOMESCO Finland

Pure tone audiometry

4.7

91.7

347

853

H29

ICPC

Ear symptom/complaint other

4.1

86.6

376

1052

H04

ICPC

Ear discharge

8.9

85.7

191

234

J01DB01

ATC

cefalexin; oral

3.2

84.8

1850

14491

H60.1

ICD-10 Finland

Cellulitis of external ear

23.1

82.3

120

H65.3

ICD-10 Finland

Chronic mucoid otitis media

9.9

78.2

163

177

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

45.7

74.9

J01MA02

ATC

ciprofloxacin; systemic

2.4

73.7

954

5435

H60.0

ICD-10 Finland

Abscess of external ear

63.9

69.0

H71

ICD-10 Finland

Cholesteatoma of middle ear

22.5

68.9

101

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

67.7

1223

8048

H61.8

ICD-10 Finland

Other specified disorders of external ear

49.4

67.0

DC1AD

NOMESCO Finland

Temporalbone CT

17.4

66.2

106

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.0

63.4

436

1707

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

8.8

60.0

133

160

J01DA01

ATC

[U] cefalexin; systemic

2.1

57.9

1412

10262

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

69.6

53.4

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

10.4

53.3

107

108

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.3

51.4

203

508

H92.0

ICD-10 Finland

Otalgia

4.5

50.7

190

451

H70.1

ICD-10 Finland

Chronic mastoiditis

51.4

50.1

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

7.1

49.4

125

185

Z2221

NOMESCO Finland

Medical doctor

2.2

48.6

680

3813

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

5.3

46.1

148

297

TDA90

NOMESCO Finland

Removal wax from ear

11.3

45.9

Z97.4

ICD-10 Finland

Presence of external hearing-aid

5.0

45.4

154

329

H13

ICPC

Plugged feeling ear

2.4

45.0

438

2058

J01FF01

ATC

clindamycin; systemic

2.1

44.5

636

3575

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.6

43.2

116

D07AC01

ATC

betamethasone; topical

2.0

43.2

768

4704

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

42.8

923

6074

H65.2

ICD-10 Finland

Chronic serous otitis media

11.9

41.8

H65.0

ICD-10 Finland

Acute serous otitis media

9.3

41.6

R01AD09

ATC

mometasone; nasal

1.9

41.6

987

6703

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

78.4

41.0

H02AB06

ATC

prednisolone; systemic

1.9

40.6

997

6827

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.3

40.2

428

2090

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

18.4

39.4

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

39.1

641

3771

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

39.1

312

1305

H81

ICPC

Excessive ear wax

2.4

39.0

373

1722

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.1

39.0

536

2934

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.0

38.8

632

3704

J01CA04

ATC

amoxicillin; systemic

2.1

38.8

1720

14395

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

37.7

311

1326

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

37.6

237

854

DFF15

NOMESCO Finland

Speech audiometry

4.5

36.9

137

321

E0000UV

ATC

1.8

36.3

851

5663

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

35.6

624

3738

Z3226

NOMESCO Finland

Physiotherapist

2.1

34.9

441

2311

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

34.8

424

2188

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.5

33.9

103

194

H02AB07

ATC

prednisone; oral

2.3

33.4

345

1645

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.6

32.6

117

265

H60.4

ICD-10 Finland

Cholesteatoma of external ear

62.7

32.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

31.3

751

4971

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

30.9

360

1809

N02BE01

ATC

paracetamol; systemic, rectal

1.9

30.7

1757

15173

N02AX02

ATC

tramadol; systemic, rectal

1.7

30.6

870

6062

R5120

NOMESCO Finland

Preparation of an aid

5.3

30.3

186

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

30.1

591

3648

DAX08

NOMESCO Finland

Fitting of hearing aid

4.2

30.1

119

297

J01FA10

ATC

azithromycin; systemic

1.7

29.7

1222

9458

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

29.2

469

2687

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

28.9

260

1153

R03AC02

ATC

salbutamol; inhalant

1.7

28.5

1078

8103

A02BC02

ATC

pantoprazole; systemic

1.7

28.4

1298

10281

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

28.3

808

5596

WX110

NOMESCO Finland

Local anesthesy

1.7

27.9

1414

11506

D07XC01

ATC

betamethasone, combinations; topical

2.3

27.8

282

1325

Z3231

NOMESCO Finland

Registered nurse

1.8

27.7

602

3822

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

101.4

27.7

R4110

NOMESCO Finland

Physiotherapy

1.8

27.7

562

3490

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

27.4

396

2174

J01MA12

ATC

levofloxacin; systemic

2.0

27.3

399

2198

R01AD08

ATC

fluticasone; nasal

1.8

27.3

613

3935

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

27.1

854

6063

J01DA06

ATC

[U] cefuroxime; systemic

2.1

27.1

344

1789

J01FA09

ATC

clarithromycin; systemic

1.8

26.9

663

4376

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

26.7

1120

8600

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

5.4

26.6

154

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

25.9

929

6816

ZXA00

NOMESCO Finland

Right side

1.8

25.8

548

3438

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

25.6

580

3714

H66

ICD-10 Finland

Suppurative and unspecified otitis media

4.7

25.4

193

A46

ICD-10 Finland

Erysipelas

2.2

25.3

297

1489

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.2

25.1

287

1424

D07AC13

ATC

mometasone; topical

1.7

25.0

612

4009

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

7.2

24.2

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

56.7

24.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

24.0

1420

11771

M25.5

ICD-10 Finland

Pain in joint

1.7

23.8

581

3794

P01AB01

ATC

metronidazole; oral, rectal

1.6

23.5

788

5628

J01AA02

ATC

doxycycline; systemic

1.7

23.5

1553

13222

DCD00

NOMESCO Finland

Myringoplasty

13.0

23.4

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

10.9

23.1

J02AC01

ATC

fluconazole; systemic

1.6

23.1

805

5801

R51.80

ICD-10 Finland

Headache

2.0

22.4

320

1738

R06AE07

ATC

cetirizine; oral

1.6

22.2

878

6517

R74

ICPC

Upper respiratory infection acute

1.7

22.1

583

3881

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

17.3

21.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

21.7

346

1955

K02.1

ICD-10 Finland

Caries of dentine

1.6

21.5

1134

9006

WX002

NOMESCO Finland

Sedation and analgesia

1.8

21.4

404

2422

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

21.4

973

7456

D07CC01

ATC

betamethasone and antibiotics; topical

2.0

21.2

284

1497

ZXA05

NOMESCO Finland

Left side

1.7

21.2

503

3239

Z71.8

ICD-10 Finland

Other specified counselling

1.7

21.2

493

3158

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

8.6

20.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

20.7

428

2637

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

20.7

526

3455

J01FA06

ATC

roxithromycin; oral

1.6

20.6

791

5796

AA1AD

NOMESCO Finland

CT of head and brain

1.8

20.5

448

2807

R42

ICD-10 Finland

Dizziness and giddiness

1.8

20.3

414

2536

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

20.3

175

752

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

19.9

359

2113

Z01.2

ICD-10 Finland

Dental examination

1.6

19.9

836

6248

L17

ICPC

Foot/toe symptom/complaint

1.7

19.9

494

3216

G47.3

ICD-10 Finland

Sleep apnoea

1.8

19.8

424

2638

N03AX16

ATC

pregabalin; oral

1.7

19.7

469

3012

A02BA02

ATC

ranitidine; systemic

1.8

19.5

384

2325

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

19.4

434

2736

H74.1

ICD-10 Finland

Adhesive middle ear disease

15.7

19.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

19.3

727

5280

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

22.8

19.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

18.8

428

2708

M54.5

ICD-10 Finland

Low back pain

1.6

18.7

637

4503

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

18.7

216

1070

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

18.5

474

3104

S18

ICPC

Laceration/cut

1.5

18.4

791

5910

M79.6

ICD-10 Finland

Pain in limb

1.6

18.4

688

4976

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

18.4

855

6505

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

18.0

773

5767

R05

ICPC

Cough

1.7

17.8

440

2847

D07AD01

ATC

clobetasol; topical

1.8

17.7

315

1836

J20

ICD-10 Finland

Acute bronchitis

2.1

17.6

202

998

H02AB04

ATC

methylprednisolone; systemic

1.9

17.5

296

1699

S29

ICPC

Skin symptom/complaint other

1.8

17.4

329

1960

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

17.4

652

4700

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

17.4

295

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

17.2

596

4217

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

12.7

17.1

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

5.3

17.1

100

E000001

ATC

1.7

17.0

425

2752

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

16.9

1040

8353

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.0

16.9

335

R05FB02

ATC

cough suppressants and expectorants

1.5

16.8

709

5245

ZXD20

NOMESCO Finland

Day surgery

1.9

16.8

265

1482

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

35.3

16.7

J01DC02

ATC

cefuroxime; systemic

2.5

16.6

135

565

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

27.8

16.5

WX290

NOMESCO Finland

Other blockade of nerve

1.5

16.4

866

6724

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

16.3

499

3414

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

16.2

445

2955

T90

ICPC

Diabetes non-insulin dependent

1.6

15.9

423

2786

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

15.9

420

2762

T16

ICD-10 Finland

Foreign body in ear

7.1

15.8

WX892

NOMESCO Finland

Monitored bed care

2.3

15.8

157

726

R06.0

ICD-10 Finland

Dyspnoea

1.6

15.8

452

3034

M03BX02

ATC

tizanidine; oral

1.5

15.8

1198

9989

M01AE02

ATC

naproxen; oral, rectal

1.5

15.7

1103

9050

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

15.7

173

840

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

15.7

1808

16522

H60.2

ICD-10 Finland

Malignant otitis externa

85.7

15.6

N06AX11

ATC

mirtazapine; oral

1.5

15.5

582

4174

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.0

15.4

199

1032

H02

ICPC

Hearing complaint

1.9

15.2

219

1185

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

15.1

458

3115

N05AH04

ATC

quetiapine; oral

1.7

15.1

312

1908

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

8.2

15.0

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

15.0

818

6356

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

15.0

159

760

E66.8

ICD-10 Finland

Other obesity

2.4

14.9

124

526

D07AB08

ATC

desonide; topical

1.9

14.8

218

1186

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

31.9

14.8

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

31.9

14.8

ZXE00

NOMESCO Finland

One hour or less

1.5

14.8

770

5921

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

14.7

394

2592

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

14.6

144

664

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

14.6

1361

11730

RK320

NOMESCO Finland

6.5

14.4

R02

ICPC

Shortness of breath/dyspnoea

1.9

14.3

229

1285

R06AX27

ATC

desloratadine; oral

1.5

14.3

510

3604

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

14.3

100

384

KMAK

NOMESCO Finland

1.4

14.2

1004

8181

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

14.1

461

3186

N07CA01

ATC

betahistine; oral

2.2

14.0

145

684

S02CA06

ATC

dexamethasone and antiinfectives; otic

7.3

14.0

L28

ICPC

Limited function/disability (L)

1.8

14.0

268

1597

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

14.0

544

3919

Z2446

NOMESCO Finland

Social worker

2.2

13.9

142

666

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

13.9

431

2940

ZXD05

NOMESCO Finland

Urgent procedure

1.5

13.9

596

4387

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.8

1257

10720

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

17.7

13.8

J34.2

ICD-10 Finland

Deviated nasal septum

2.4

13.8

114

482

DCD10

NOMESCO Finland

Tympanoplasty

23.9

13.8

A02BC05

ATC

esomeprazole; systemic

1.5

13.6

748

5788

A10BA02

ATC

metformin; oral

1.5

13.6

492

3482

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

13.6

189

1007

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

13.6

326

2078

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

13.5

189

1010

WX722

NOMESCO Finland

PEEP

2.5

13.5

106

436

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

13.5

192

1032

EBA00

NOMESCO Finland

Extraction of tooth

1.5

13.4

621

4635

L15

ICPC

Knee symptom/complaint

1.6

13.2

387

2604

N06AB10

ATC

escitalopram; oral

1.6

13.2

377

2520

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

13.1

195

1064

ZXA10

NOMESCO Finland

Bilateral

1.6

13.1

347

2269

H71

ICPC

Acute otitis media/myringitis

5.1

13.0

UJF32

NOMESCO Finland

Coloscopy

1.5

13.0

460

3235

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

13.0

261

1579

R03BA02

ATC

budesonide; inhalant

1.6

13.0

328

2120

DEB30

NOMESCO Finland

Radical mastoidectomy

28.5

13.0

R03BB04

ATC

tiotropium bromide; inhalant

1.9

12.9

188

1019

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

12.9

162

830

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

12.8

299

1889

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

12.8

232

1358

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

12.8

200

1114

C07AB07

ATC

bisoprolol; oral

1.4

12.8

814

6459

H51

ICPC

Ear, I&d/flush/aspiration

5.0

12.8

L01

ICPC

Neck symptom/complaint

1.7

12.8

257

1555

XQ800

NOMESCO Finland

Prick test

2.1

12.8

154

777

J01DA08

ATC

[U] cefaclor; oral

1.8

12.7

223

1291

A02BC01

ATC

omeprazole; systemic

1.5

12.7

492

3527

J01MA01

ATC

ofloxacin; systemic

2.0

12.7

160

821

N06AX16

ATC

venlafaxine; oral

1.7

12.7

258

1566

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

12.6

138

668

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

12.6

986

8118

R60.0

ICD-10 Finland

Localized oedema

1.9

12.6

197

1097

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.6

676

5187

M01AB05

ATC

diclofenac; systemic, rectal

1.4

12.6

1270

10942

A01AB09

ATC

miconazole; local oral

2.0

12.5

159

820

DEB00

NOMESCO Finland

Cortical mastoidectomy

+∞

12.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

12.5

354

2356

N05BA01

ATC

diazepam; systemic, rectal

1.8

12.5

246

1478

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

12.4

701

5430

R03DC03

ATC

montelukast; oral

1.7

12.3

299

1908

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

12.3

1093

9186

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.7

12.3

326

C03CA01

ATC

furosemide; systemic

1.5

12.3

453

3209

R53

ICD-10 Finland

Malaise and fatigue

1.6

12.3

368

2484

X58

ICD-10 Finland

Exposure to other specified factors

1.7

12.3

261

1604

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

12.2

262

1615

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

12.1

739

5801

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

5.9

12.1

H70.0

ICD-10 Finland

Acute mastoiditis

21.4

12.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

12.0

235

1407

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

12.0

188

1049

J01DC04

ATC

cefaclor; oral

4.5

11.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

11.9

139

693

A04

ICPC

Weakness/tiredness general

1.8

11.9

231

1383

RK110

NOMESCO Finland

6.2

11.8

S76

ICPC

Skin infection other

2.3

11.7

106

469

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

11.7

161

857

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

11.7

467

3365

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.7

508

3726

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

11.7

224

1336

G44.2

ICD-10 Finland

Tension-type headache

1.7

11.6

245

1499

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

11.6

250

1543

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

11.6

154

808

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

11.5

377

R01AD12

ATC

fluticasone furoate; nasal

1.5

11.5

539

4010

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

11.5

127

616

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

11.4

299

1945

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

11.4

197

1134

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.4

11.3

394

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

11.3

337

2267

L03

ICPC

Low back symptom/complaint

1.5

11.3

424

3013

XF402

NOMESCO Finland

ECG with work load test

1.8

11.3

210

1239

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

11.2

355

2422

Z01.7

ICD-10 Finland

Laboratory examination

1.8

11.2

201

1170

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

11.2

731

5793

P99

ICPC

Psychological disorders other

3.1

11.1

192

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

11.1

415

2941

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

11.1

405

N05BA04

ATC

oxazepam; oral

1.5

11.1

440

3162

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

11.0

475

3473

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

11.0

198

1155

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

7.1

11.0

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

11.0

155

831

A02BC03

ATC

lansoprazole; oral

1.5

11.0

520

3875

R4120

NOMESCO Finland

Occupational therapy

2.1

11.0

123

601

H61.9

ICD-10 Finland

Disorder of external ear, unspecified

13.9

11.0

D11

ICPC

Diarrhoea

1.8

11.0

211

1259

-60

ICPC

Result test/procedure

2.2

10.9

113

535

R21

ICPC

Throat symptom/complaint

1.5

10.8

371

2579

-1

NOMESCO Finland

1.4

10.8

632

4900

RK520

NOMESCO Finland

9.6

10.7

A11

ICPC

Chest pain NOS

2.0

10.7

141

738

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.2

10.7

103

473

H03AA01

ATC

levothyroxine sodium; systemic

1.5

10.7

405

2876

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

10.7

342

2340

D07AA02

ATC

hydrocortisone; topical

1.6

10.7

261

1667

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

10.7

147

784

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

10.6

455

3322

R03BA05

ATC

fluticasone; inhalant

1.6

10.6

335

2287

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

10.5

222

1360

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

10.5

284

1861

WX320

NOMESCO Finland

Spinalanesthesy

1.5

10.5

399

2836

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

10.5

103

474

UKC02

NOMESCO Finland

Cystoscopy

1.6

10.5

276

1795

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

10.5

184

1064

R03BA01

ATC

beclometasone; inhalant

1.6

10.5

253

1611

N06AB04

ATC

citalopram; systemic

1.5

10.5

385

2720

3801A

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA ACUTA DIFFUSA]

+∞

10.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

10.4

296

1968

XQ802

NOMESCO Finland

Epicutan test

2.4

10.4

385

Z00.0

ICD-10 Finland

General medical examination

1.6

10.4

326

2221

DFF16

NOMESCO Finland

Speech-in-noise audiometry

32.7

10.3

D07XB02

ATC

triamcinolone, combinations; topical

4.4

10.3

J01AA07

ATC

tetracycline; systemic

1.6

10.2

281

1849

L29.9

ICD-10 Finland

Pruritus, unspecified

3.2

10.2

165

DGW00

NOMESCO Finland

Dilatation of eustachian tube

23.5

10.2

E000006

ATC

2.0

10.2

137

723

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.5

10.2

325

N06AX21

ATC

duloxetine; oral

1.7

10.1

198

1184

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

4.7

10.1

T89

ICPC

Diabetes insulin dependent

2.4

10.1

347

H81.0

ICD-10 Finland

Ménière disease

3.3

10.0

151

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

10.0

412

R01AD05

ATC

budesonide; nasal

1.9

10.0

151

832

L12

ICPC

Hand/finger symptom/complaint

1.6

9.9

254

1642

M75

ICD-10 Finland

Shoulder lesions

2.3

9.9

383

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.7

9.9

248

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

9.9

233

1471

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

9.9

154

859

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

9.9

159

894

R06AE09

ATC

levocetirizine; oral

1.6

9.8

265

1738

WZA90

NOMESCO Finland

Other doctors statement

1.5

9.8

414

3005

J45

ICD-10 Finland

Asthma

1.8

9.8

169

972

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

9.7

177

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

9.7

429

3142

C08CA01

ATC

amlodipine; oral

1.4

9.7

574

4445

J37.0

ICD-10 Finland

Chronic laryngitis

2.6

9.7

260

DFE00

NOMESCO Finland

Insertion of cochlear implant

13.4

9.7

J02AC02

ATC

itraconazole; systemic

1.5

9.7

322

2219

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

9.7

266

1752

DC1BD

NOMESCO Finland

Temporal bone extensive CT

55.2

9.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

9.6

175

1023

H73.0

ICD-10 Finland

Acute myringitis

7.8

9.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

9.6

195

1181

H25.8

ICD-10 Finland

Other senile cataract

1.8

9.6

166

958

J01FA01

ATC

erythromycin; systemic

1.6

9.6

262

1722

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

10.1

9.5

H80.9

ICD-10 Finland

Otosclerosis, unspecified

5.7

9.5

A10AE04

ATC

insulin glargine; parenteral

1.8

9.5

174

1023

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

9.4

247

1606

RK530

NOMESCO Finland

100.4

9.4

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

100.4

9.4

4122

FHL

Tympanostomy (tympanic tube)

4.2

9.4

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

9.4

669

5342

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

12.4

9.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

9.3

390

2823

XF404

NOMESCO Finland

Ambulatory ECG

1.8

9.3

162

936

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

9.3

660

5267

RK120

NOMESCO Finland

10.7

9.3

A07AA02

ATC

nystatin; oral

2.0

9.3

111

560

R03AC13

ATC

formoterol; inhalant

2.2

9.2

428

D05AX52

ATC

calcipotriol, combinations; topical

2.0

9.2

109

548

A06AD11

ATC

lactulose; oral

1.6

9.2

236

1525

H3603, E113

ICD-10 Finland

5.7

9.2

P01

ICPC

Feeling anxious/nervous/tense

1.7

9.2

183

1102

R03DA04

ATC

theophylline; systemic, rectal

2.2

9.2

419

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

9.2

419

A03

ICPC

Fever

1.5

9.1

295

2021

J01AA04

ATC

lymecycline; systemic

1.6

9.1

239

1553

R05

ICD-10 Finland

Cough

1.5

9.1

336

2368

R03AC03

ATC

terbutaline; inhalant

1.6

9.0

240

1567

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

9.0

150

852

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

9.0

129

698

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

9.0

121

640

H73.1

ICD-10 Finland

Chronic myringitis

18.7

8.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

8.9

285

1944

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

8.9

259

1730

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

8.8

U07

ICPC

Urine symptom/complaint other

2.1

8.8

490

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

4.2

8.7

E66

ICD-10 Finland

Obesity

2.2

8.7

389

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

8.5

112

587

U13

ICPC

Bladder symptom/complaint other

2.7

8.5

212

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.0

8.5

154

E000003

ATC

2.1

8.5

446

S09

ICPC

Infected finger/toe

2.5

8.5

249

K07.60

ICD-10 Finland

Snapping jaw

2.1

8.5

461

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

8.5

138

780

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

8.4

197

1242

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

8.4

242

L05

ICPC

Flank/axilla symptom/complaint

2.1

8.4

476

B01AB05

ATC

enoxaparin; parenteral

1.4

8.4

511

3957

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.3

8.4

319

L13

ICPC

Hip symptom/complaint

1.5

8.4

255

1720

K30

ICD-10 Finland

Functional dyspepsia

1.7

8.4

180

1108

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

4.1

8.4

A01AB04

ATC

amphotericin B; local oral

2.2

8.3

396

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

+∞

8.3

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

8.3

463

3536

S02AA03

ATC

boric acid; otic

4.6

8.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

8.3

156

925

A28

ICPC

Limited function/disability NOS

1.6

8.3

226

1485

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

8.2

114

611

S74

ICPC

Dermatophytosis

3.3

8.2

119

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

8.2

161

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.2

193

1218

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

8.2

467

A99

ICPC

Disease/condition unspecnature/site

1.8

8.2

132

746

L20.0

ICD-10 Finland

Besnier prurigo

1.9

8.2

119

650

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

8.1

100

512

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.1

108

569

K03.66

ICD-10 Finland

Tooth plaque

1.9

8.1

122

674

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

8.0

145

852

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.7

8.0

203

H3603, E103

ICD-10 Finland

4.1

8.0

P03

ICPC

Feeling depressed

1.7

8.0

155

930

D01

ICPC

Abdominal pain/cramps general

1.6

7.9

187

1182

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

7.9

166

1015

M01AX17

ATC

nimesulide; oral

1.4

7.9

405

3040

A11CC03

ATC

alfacalcidol; systemic

2.8

7.9

183

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.3

7.9

299

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.9

7.9

113

614

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

7.9

271

A98

ICPC

Health maint/preventive medicine

1.6

7.9

1962

18808

R50.9

ICD-10 Finland

Fever, unspecified

1.5

7.9

235

1580

H27

ICPC

Fear of ear disease

3.9

7.8

L04AA01

ATC

[U] ciclosporin; systemic

3.7

7.8

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

7.8

401

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

7.8

108

579

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

7.8

123

688

A12AA04

ATC

calcium carbonate; oral

3.3

7.8

114

M79.1

ICD-10 Finland

Myalgia

1.6

7.8

225

1500

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

7.8

327

M01AH05

ATC

etoricoxib; oral

1.3

7.8

1063

9269

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

7.8

517

4059

XG405

NOMESCO Finland

Education on PEF monitoring

3.7

7.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

7.7

130

743

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.3

7.7

109

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

7.7

205

N03AG01

ATC

valproic acid; systemic, rectal

1.9

7.7

109

587

L14

ICPC

Leg/thigh symptom/complaint

1.8

7.7

130

746

J01MA14

ATC

moxifloxacin; systemic

1.7

7.7

149

891

A10BB12

ATC

glimepiride; oral

1.8

7.7

119

664

N30.0

ICD-10 Finland

Acute cystitis

1.6

7.7

217

1439

R03AC12

ATC

salmeterol; inhalant

2.1

7.7

376

F29

ICPC

Eye symptom/complaint other

1.8

7.7

137

802

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

7.6

480

K04.0

ICD-10 Finland

Pulpitis

1.7

7.6

160

980

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

7.6

163

1005

N05CF01

ATC

zopiclone; oral

1.3

7.6

536

4250

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

7.6

161

N01

ICPC

Headache

1.6

7.6

179

1134

H61.0

ICD-10 Finland

Perichondritis of external ear

25.1

7.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

7.6

106

570

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

7.6

359

UDM02

NOMESCO Finland

Sinoscopy

2.8

7.5

168

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

10.1

7.5

M01AB51

ATC

indometacin, combinations; oral, rectal

2.9

7.5

156

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

7.5

100

530

L60.0

ICD-10 Finland

Ingrowing nail

2.2

7.5

352

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

7.5

400

A29

ICPC

General symptom/complaint other

1.6

7.4

176

1113

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.7

7.4

165

1029

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.1

7.4

390

DCA00

NOMESCO Finland

Biopsy of tympanic membrane or middle ear

80.3

7.4

127

Kela drug reimbursment

Transplant complication

3.2

7.4

113

R51

ICD-10 Finland

Headache

1.9

7.4

498

N06AA09

ATC

amitriptyline; systemic

1.6

7.3

167

1046

N03AX12

ATC

gabapentin; oral

1.5

7.3

259

1807

R06AX22

ATC

ebastine; oral

1.5

7.3

296

2124

N05AA02

ATC

levomepromazine; systemic

2.1

7.3

362

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

7.3

152

929

K08.80

ICD-10 Finland

Toothache NOS

1.7

7.3

140

836

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

7.3

387

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

7.3

121

693

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

7.2

200

1317

L84

ICD-10 Finland

Corns and callosities

2.3

7.2

278

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

7.2

109

601

J46

ICD-10 Finland

Status asthmaticus

2.6

7.2

185

L08

ICPC

Shoulder symptom/complaint

1.4

7.2

313

2278

M02AA10

ATC

ketoprofen; topical

1.5

7.2

253

1762

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

7.2

129

756

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.6

7.2

N17

ICPC

Vertigo/dizziness

1.6

7.2

178

1144

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

7.2

173

1101

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

7.2

474

H83.1

ICD-10 Finland

Labyrinthine fistula

30.1

7.1

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

4.4

7.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

7.1

187

1218

RK420

NOMESCO Finland

20.1

7.1

S21

ICPC

Skin texture symptom/complaint

1.6

7.1

205

1366

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

7.1

104

568

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

7.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

7.1

413

L04AA06

ATC

mycophenolic acid; systemic

3.0

7.0

129

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

7.0

356

2662

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.7

7.0

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

7.0

184

1197

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

7.0

486

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.7

7.0

169

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

7.0

149

919

Y94.0

ICD-10 Finland

Accident at home

3.1

7.0

113

A10BH05

ATC

linagliptin; oral

2.0

7.0

394

R35

ICD-10 Finland

Polyuria

1.8

7.0

109

611

L16

ICPC

Ankle symptom/complaint

1.6

7.0

171

1093

R83

ICPC

Respiratory infection other

1.4

6.9

410

3154

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

6.9

451

XCK00

NOMESCO Finland

Perimetry

1.8

6.9

105

583

R31

ICD-10 Finland

Unspecified haematuria

1.6

6.9

158

991

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

6.9

424

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.9

259

1827

R06.5

ICD-10 Finland

Mouth breathing

1.7

6.9

150

930

K05.08

ICD-10 Finland

Another acute gingivitis

2.7

6.9

171

1450

FHL

Otomicroscopy

7.5

6.9

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

6.9

208

1399

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

6.9

413

3182

ZXC10

NOMESCO Finland

Use of laser

2.6

6.9

188

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

6.9

187

1227

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

6.9

235

1627

D01AC02

ATC

miconazole; topical

1.7

6.8

133

800

H02BX01

ATC

methylprednisolone, combinations; systemic

2.0

6.8

459

C09CA01

ATC

losartan; oral

1.4

6.8

372

2820

U71

ICPC

Cystitis/urinary infection other

1.9

6.8

533

P06

ICPC

Sleep disturbance

1.6

6.8

162

1030

D01AE15

ATC

terbinafine; topical

1.8

6.8

122

714

G51.0

ICD-10 Finland

Bell palsy

2.5

6.8

208

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

6.8

519

G04AC01

ATC

2.5

6.8

198

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

6.8

334

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

6.8

220

1508

C09CA06

ATC

candesartan; oral

1.4

6.8

337

2513

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.5

6.8

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

6.8

208

1405

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

40.2

6.8

R11

ICD-10 Finland

Nausea and vomiting

1.7

6.8

130

776

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

6.7

161

1022

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.5

6.7

211

Z2445

NOMESCO Finland

Psychologist

2.0

6.7

387

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

6.7

514

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

22.6

6.7

H80.8

ICD-10 Finland

Other otosclerosis

22.6

6.7

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

22.6

6.7

A10AE05

ATC

insulin detemir; parenteral

1.8

6.7

101

561

S80.0

ICD-10 Finland

Contusion of knee

1.8

6.7

108

612

U02

ICPC

Urinary frequency/urgency

1.5

6.6

204

1380

A87

ICPC

Complication of medical treatment

5.2

6.6

S04

ICPC

Lump/swelling localized

1.6

6.6

155

979

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

6.6

139

854

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

6.6

172

1118

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

6.6

142

879

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.6

487

3877

M54

ICD-10 Finland

Dorsalgia

1.6

6.6

187

1243

P29

ICPC

Psychological sympt/compl other

1.9

6.6

525

R07.3

ICD-10 Finland

Other chest pain

1.6

6.6

156

989

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

6.5

140

865

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

6.5

179

1178

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

6.5

454

UJH02

NOMESCO Finland

Anoscopy

2.1

6.5

361

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

6.5

426

SPAT1254

SPAT

Administration of medicine

1.5

6.5

238

1672

N05AX08

ATC

risperidone; systemic

1.7

6.5

118

696

DFF59

NOMESCO Finland

Other assessment of balance

4.1

6.5

137

Kela drug reimbursment

Uraemia requiring dialysis

4.1

6.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

6.5

105

596

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

6.5

138

852

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

6.5

472

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.5

139

857

M02AA07

ATC

piroxicam; topical

1.3

6.5

600

4931

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

6.5

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

6.5

405

EMB10

NOMESCO Finland

Tonsillectomy

1.8

6.4

537

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.1

6.4

330

A08

ICPC

Swelling

2.1

6.4

343

H74

ICPC

Chronic otitis media

70.0

6.4

D06

ICPC

Abdominal pain localized other

1.7

6.4

132

804

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

6.4

280

2035

K04.08

ICD-10 Finland

Other specified pulpit

1.8

6.4

108

621

R52.9

ICD-10 Finland

Pain, unspecified

1.7

6.4

137

845

R52.2

ICD-10 Finland

Other chronic pain

2.2

6.4

263

A91

ICPC

Abnormal result investigation NOS

2.1

6.4

331

A10BH01

ATC

sitagliptin; oral

1.6

6.4

150

951

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

6.4

351

2663

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

14.3

6.4

H26.4

ICD-10 Finland

After-cataract

1.7

6.4

120

713

N05CD07

ATC

temazepam; oral

1.5

6.4

188

1261

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

6.4

100

560

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

6.4

165

1071

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

6.4

154

981

R2110

NOMESCO Finland

Giving the first information

1.7

6.4

118

699

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.1

6.4

323

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.4

488

3904

J33.8

ICD-10 Finland

Other polyp of sinus

2.6

6.3

162

N03AX11

ATC

topiramate; oral

2.5

6.3

197

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

6.3

141

879

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.3

6.3

245

R78

ICPC

Acute bronchitis/bronchiolitis

2.6

6.3

169

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

6.6

6.3

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.3

430

ZXD35

NOMESCO Finland

Usual procedure

2.2

6.3

291

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

6.3

362

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

6.3

125

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.3

324

2432

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

9.3

6.3

DED00

NOMESCO Finland

Obliteration of cavity after partial excision of mastoid

+∞

6.3

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

26.7

6.2

A03FA02

ATC

cisapride; oral, rectal

1.7

6.2

120

718

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

2.6

6.2

165

L04AX01

ATC

azathioprine; systemic

2.0

6.2

385

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

6.2

334

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.8

6.2

516

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.8

6.2

J01CF05

ATC

flucloxacillin; systemic

2.1

6.1

310

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

6.1

337

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

6.1

301

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.8

6.1

100

570

S22

ICPC

Nail symptom/complaint

1.8

6.1

555

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

6.1

539

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

6.1

533

4339

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.5

6.1

174

1156

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.0

6.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

6.1

224

1575

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

6.1

161

Z50.1

ICD-10 Finland

Other physical therapy

1.8

6.0

513

NBE15

NOMESCO Finland

Incision or suture of capsule of joint of shoulder, arthroscopic

10.0

6.0

N03AX09

ATC

lamotrigine; oral

1.9

6.0

454

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

6.0

149

958

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

6.0

230

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

6.0

871

7562

C01CA24

ATC

epinephrine; parenteral

1.7

6.0

106

619

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

770

2142

4.87

260.96

2.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

568

2152

3.17

112.25

2.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

526

2652

2.27

54.11

2.2

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1103

7366

1.94

52.51

2.2

1.9

pmol/l

95.9

95.3

0.14

570

3924

(42870588) Differential panel, method unspecified - Blood

972

6340

1.91

48.56

6.7

5.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1261

9068

1.85

45.26

6.8

5.9

57.2

56.9

0.26

1167

8540

(3022096) Basophils/100 leukocytes in Blood

1214

8630

1.85

45.20

7.1

6.0

0.7

1.34

1117

8096

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

440

2205

2.23

45.13

4.8

4.3

31.8

32.3

0.39

308

1536

(3006504) Eosinophils/100 leukocytes in Blood

1236

8893

1.83

43.68

7.0

6.0

2.9

2.8

0.54

1141

8328

(3019069) Monocytes/100 leukocytes in Blood

1239

8938

1.82

43.24

7.4

6.3

8.5

8.6

0.49

1142

8416

(3002030) Lymphocytes/100 leukocytes in Blood

1264

9196

1.82

42.67

7.2

6.0

28.2

28.3

0.03

1166

8629

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1151

8204

1.80

41.02

6.9

6.1

mmol/l

1.2

2.99

1055

7437

(3033658) Prothrombin time (PT) actual/Normal

748

4741

1.85

38.82

4.2

3.8

91.9

90.7

0.61

729

4609

(3013115) Eosinophils [#/volume] in Blood

1308

9830

1.75

37.47

7.0

6.1

e9/l

0.2

1.82

1140

8675

(3006315) Basophils [#/volume] in Blood

1269

9506

1.73

36.30

6.9

5.8

e9/l

0.0

2.20

1079

8267

(3019198) Lymphocytes [#/volume] in Blood

1293

9746

1.73

36.08

6.8

5.9

e9/l

2.0

0.04

1140

8645

(3001604) Monocytes [#/volume] in Blood

1264

9471

1.73

36.00

6.8

5.8

e9/l

0.6

2.48

1081

8230

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1751

14470

1.84

34.70

8.3

7.4

u/l

76.6

77.8

0.54

1667

13648

(3013707) Erythrocyte sedimentation rate by Westergren method

1704

13980

1.81

34.41

4.7

4.0

mm/h

12.5

11.7

1.38

1579

12976

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

505

2919

1.93

34.25

3.0

2.9

e6/l

3.4

2.3

1.31

290

1591

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1210

9061

1.70

33.63

8.1

6.8

mmol/l

1.2

1.63

1089

7660

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1269

9680

1.68

32.40

5.6

6.1

umol/l

10.5

11.4

3.24

1203

9176

(3013826) Glucose [Moles/volume] in Serum or Plasma

1399

10961

1.69

32.16

5.3

4.8

mmol/l

6.9

6.7

2.06

1320

10214

(3037467) Urinalysis macro (dipstick) panel - Urine

1597

12974

1.73

32.01

5.2

4.1

—

(3019225) pH of Specimen

340

1779

2.07

30.32

5.3

4.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

332

1727

2.08

30.06

2.6

2.4

u/l

28.5

67.8

0.81

274

1476

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

231

1041

2.35

29.84

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

690

4561

1.73

29.47

2.5

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1393

11047

1.65

29.21

9.4

8.9

e9/l

4.2

4.1

0.39

1184

9691

(3044640) Blood type and Crossmatch panel - Blood

845

5937

1.66

28.51

2.5

2.4

—

(40768804) Tissue Pathology biopsy report

1030

7621

1.63

28.21

2.3

2.1

—

(40758558) Short blood count panel - Blood

715

4826

1.69

28.01

6.7

6.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1987

17493

1.92

27.16

5.7

4.6

mu/l

1.9

2.1

1.00

1806

16133

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2121

19124

2.20

26.84

18.3

13.6

mg/l

22.2

23.3

0.86

1795

15068

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

502

3101

1.79

26.81

2.9

2.7

e6/l

1.0

1.1

0.43

286

1761

(3018095) Leukocytes [#/volume] in Urine

902

6556

1.61

25.94

4.3

3.6

e6/l

104.9

107.4

0.03

617

4598

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

471

2886

1.79

25.74

2.0

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

173

738

2.45

25.17

5.1

4.3

mmol/l

24.7

24.9

0.32

160

698

(3024561) Albumin [Mass/volume] in Serum or Plasma

1041

7884

1.58

24.82

5.6

4.9

g/l

35.7

0.01

959

7332

(3007164) IgA [Mass/volume] in Serum or Plasma

576

3778

1.70

24.58

1.5

g/l

2.5

2.4

0.42

308

2354

(3022217) INR in Platelet poor plasma by Coagulation assay

384

2246

1.85

24.33

24.5

23.4

inr

1.1

1.3

3.73

343

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2003

17847

1.86

24.01

16.3

12.4

ml/min/173m2

83.7

83.0

0.68

1687

14697

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

766

5459

1.60

23.31

2.1

u/l

165.1

234.6

1.78

729

5135

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

537

3503

1.69

23.21

3.9

3.6

ng/l

482.9

450.1

0.06

392

2619

(3019550) Sodium [Moles/volume] in Serum or Plasma

2133

19463

2.12

23.09

20.3

15.4

mmol/l

139.5

139.7

1.97

2083

18973

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1526

12744

1.57

22.70

3.6

3.1

u/l

50.8

47.6

0.58

1426

11942

(3023103) Potassium [Moles/volume] in Serum or Plasma

2136

19530

2.11

22.52

20.6

15.5

mmol/l

4.0

0.40

2080

19008

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

359

2112

1.83

22.18

2.4

2.7

umol/l

9.1

8.1

0.25

314

1841

(3019309) Folate [Moles/volume] in Red Blood Cells

499

3229

1.69

22.10

1.8

1.7

nmol/l

973.2

1161.6

5.18

353

2486

(3023368) Bacteria identified in Blood by Culture

690

4889

1.58

21.09

4.5

4.4

—

(3037522) Nuclear Ab [Titer] in Serum

412

2571

1.73

20.70

1.4

1.3

titre

487.8

512.2

0.12

526

(3021960) Folate [Moles/volume] in Serum or Plasma

599

4137

1.60

20.27

1.6

1.5

nmol/l

19.9

20.5

0.41

517

3572

(40768797) Stomach Pathology biopsy report

412

2588

1.72

20.17

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

762

5572

1.55

20.06

3.6

3.2

e6/l

40.2

98.7

2.21

590

4272

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

597

4169

1.58

19.10

1.7

mg/l

1.1

0.01

451

3165

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

985

7670

1.49

18.96

2.6

2.2

nmol/l

75.7

76.5

0.36

885

6939

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

837

6310

1.51

18.83

3.3

3.2

u/l

33.1

0.00

788

5999

(3037121) Protein [Mass/volume] in Urine

145

651

2.31

18.79

3.8

3.2

g/l

0.3

0.14

262

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1062

8412

1.48

18.68

3.2

2.8

ug/l

110.1

121.5

1.12

981

7833

(36660697) Celiac disease serology panel - Serum

265

1498

1.87

18.44

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

695

5088

1.52

17.75

3.6

3.1

e6/l

0.3

0.4

1.67

517

3825

(3022313) Gas panel - Capillary blood

175

872

2.09

17.50

5.3

4.0

—

(36304419) Bacteria [Presence] in Urine

679

4971

1.52

17.25

3.5

3.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

672

4910

1.52

17.23

2.9

3.0

ng/l

1438.1

1319.1

0.27

551

4173

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

601

4294

1.54

17.08

1.4

1.3

u/ml

1.6

1.5

0.03

1147

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1676

14661

1.51

17.07

4.5

4.0

pmol/l

14.6

14.7

0.92

1510

13426

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

154

739

2.16

16.98

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

141

658

2.22

16.66

1.9

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1909

17223

1.60

16.48

7.1

5.5

mmol/mol

41.0

39.6

7.62

1743

16026

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

216

1186

1.91

16.40

5.0

3.9

kpa

5.2

5.1

0.36

203

1106

(3026493) Urate [Moles/volume] in Serum or Plasma

662

4864

1.50

16.37

2.8

2.7

umol/l

1355.0

4972.2

3.73

573

4246

(3032080) INR in Blood by Coagulation assay

928

7288

1.45

16.37

7.6

9.0

inr

1.2

0.33

164

2152

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

480

3288

1.58

16.36

1.3

iu/ml

25.1

31.5

0.51

128

1043

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

206

1124

1.91

15.93

5.0

3.9

mmol/l

1.1

1.8

1.86

164

833

(3009508) Creatinine [Moles/volume] in Urine

764

5804

1.47

15.91

4.0

3.2

mmol/l

7.5

7.7

0.63

618

4941

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

641

4706

1.50

15.82

2.5

2.2

mg/l

2.9

0.07

525

4016

(3052851) Hemolysis interference index of Serum or Plasma

123

556

2.28

15.70

3.2

3.3

—

(3009343) pH of Capillary blood

210

1171

1.87

15.18

5.1

3.9

7.4

2.01

139

(3014111) Lactate [Moles/volume] in Serum or Plasma

264

1583

1.75

15.02

7.9

7.5

mmol/l

1.3

1.4

0.80

256

1517

(3000991) Gas panel - Venous blood

257

1537

1.76

14.74

9.5

8.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1456

12572

1.42

14.42

3.4

3.1

—

(1761868) Lipid panel - Serum or Plasma

509

6891

0.67

14.29

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2161

20299

1.88

14.20

12.6

10.0

u/l

27.7

26.5

1.73

2089

19628

(3018418) pH of Serum or Plasma

699

5329

1.45

13.90

4.4

3.9

7.4

1.26

1019

(3012516) Albumin [Mass/volume] in Urine

701

5358

1.44

13.71

4.0

3.3

mg/l

304.0

359.3

0.14

468

3465

(3013512) EKG study

683

5227

1.43

13.16

4.2

3.7

—

(40761511) CBC panel - Blood by Automated count

2130

19995

1.75

13.00

15.8

12.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

275

1733

1.67

12.98

2.2

2.3

g/l

0.2

0.61

253

1615

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

307

1990

1.62

12.96

1.9

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

165

896

1.91

12.94

4.6

4.4

mmol/l

24.1

24.0

0.11

152

817

(3048689) Calprotectin [Mass/mass] in Stool

350

2351

1.57

12.72

2.7

2.4

ug/g

147.4

126.5

0.43

263

1883

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

172

952

1.87

12.72

10.2

mmol/l

24.2

24.3

0.11

161

899

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

743

5807

1.41

12.62

2.7

2.5

u/l

54.1

56.6

1.11

682

5371

(3020682) Albumin/Creatinine [Ratio] in Urine

724

5646

1.41

12.41

4.8

4.0

mg/mmol

10.1

8.9

0.26

482

3630

(3004789) Transferrin [Mass/volume] in Serum or Plasma

384

2648

1.54

12.40

2.8

2.4

g/l

2.3

0.45

352

2454

(3003327) Ova and parasites identified in Stool by Light microscopy

122

606

2.07

12.33

1.7

—

(3022145) Colonoscopy Study observation

312

2055

1.60

12.31

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

782

6197

1.39

12.14

3.4

mmol/l

2.4

0.17

661

5461

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

360

2459

1.55

12.12

2.9

2.5

22.5

23.4

0.74

314

2099

(3022948) Iron [Moles/volume] in Serum or Plasma

408

2867

1.51

12.04

2.8

2.5

umol/l

13.2

13.4

0.23

372

2656

(4146454)

187

2.93

11.94

3.3

2.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2147

20268

1.74

11.92

20.3

15.6

umol/l

79.0

76.5

1.97

2147

20261

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

201

1197

1.74

11.66

1.2

1.3

—

47.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1976

18308

1.52

11.64

5.4

4.4

mmol/l

6.1

5.9

6.58

1805

16786

(3017143) Hepatitis C virus Ab [Presence] in Serum

332

2249

1.56

11.57

1.9

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

388

2.29

11.53

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

388

2.29

11.53

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

302

2008

1.58

11.41

1.9

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

437

3153

1.47

11.27

1.3

1.2

u/ml

19.0

11.5

0.27

136

1263

(3024731) MCV [Entitic volume]

2232

21366

2.03

11.23

26.5

19.8

90.9

0.29

2204

21077

(3007461) Platelets [#/volume] in Blood

2231

21354

2.02

11.22

26.6

19.9

e9/l

253.1

251.8

0.42

2177

20831

(3035941) MCH [Entitic mass]

2232

21367

2.03

11.22

26.5

19.8

30.3

0.33

2205

21075

(3026361) Erythrocytes [#/volume] in Blood

2232

21369

2.03

11.18

26.6

19.8

e12/l

4.5

0.12

2173

20782

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

223

2.69

11.12

2.3

mg/l

19.8

25.5

0.49

(3010813) Leukocytes [#/volume] in Blood

2232

21373

2.02

11.11

26.7

19.9

e9/l

7.0

6.7

3.97

2175

20790

(3000963) Hemoglobin [Mass/volume] in Blood

2232

21377

2.02

11.04

26.8

19.9

g/l

135.0

135.6

1.28

2205

21083

(3011397) Hemoglobin [Presence] in Urine by Test strip

558

4240

1.42

10.85

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1911

17653

1.46

10.77

20.4

14.5

40.1

39.9

0.51

1474

13021

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

132

708

1.92

10.77

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

415

2990

1.47

10.73

3.3

3.4

mmol/l

0.8

1.67

380

2812

(3003458) Phosphate [Moles/volume] in Serum or Plasma

350

2445

1.51

10.53

7.8

5.8

mmol/l

1.0

0.19

316

2270

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

115

593

1.99

10.52

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

215

1348

1.66

10.31

5.0

4.0

ng/l

100.4

88.6

0.72

184

1186

(3026008) Bacteria identified in Urine by Culture

680

5383

1.37

10.27

3.2

3.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

838

6864

1.34

10.11

3.6

3.5

ng/l

45.4

55.4

0.29

548

4527

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.30

10.11

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

210

1317

1.65

10.06

2.4

au/ml

12.5

22.2

1.12

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

342

2401

1.50

10.02

1.7

1.5

0.95

300

2114

(4010399)

207

1295

1.66

10.01

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

224

1436

1.62

9.83

1.6

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1055

8978

1.32

9.63

4.0

4.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

627

1.91

9.59

2.3

2.5

g/l

2.9

3.1

1.26

494

(40761536) Microorganisms panel - Urine sediment

1650

0.50

9.38

4.7

3.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

102

528

1.97

9.26

1.5

1.4

ug/g

279.3

284.2

0.08

305

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

668

1.86

9.07

2.3

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

668

1.86

9.07

2.3

2.4

g/l

7.4

7.3

0.22

504

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

182

2.67

9.05

1.3

1.2

u/l

44.4

56.8

1.19

125

(3005322) IgE [Units/volume] in Serum or Plasma

192

1219

1.63

8.77

1.4

1.3

u/ml

547.2

201.0

0.72

180

1131

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

293

2048

1.49

8.73

3.9

4.2

u/l

231.6

247.3

1.49

278

1944

(3002619) Bacteria identified in Specimen by Culture

5.34

8.68

1.6

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

203

1310

1.60

8.67

1.7

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

106

571

1.90

8.59

2.1

2.5

g/l

0.1

1.1

6.02

500

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

119

668

1.82

8.48

2.3

2.4

g/l

3.7

3.8

0.83

483

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

577

7139

0.75

8.36

3.8

3.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

523

1.91

8.18

2.2

2.3

g/l

39.1

37.7

1.75

456

(3004616) Nuclear Ab [Presence] in Serum

217

2.43

8.09

1.5

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

432

3295

1.38

7.95

3.3

3.0

mmol/l

2.4

0.03

383

2887

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

225

2.39

7.95

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

225

2.39

7.95

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

378

4958

0.72

7.93

4.3

3.8

estimate

0.0

1.08

115

1703

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

389

2.04

7.90

1.2

u/ml

1.5

4.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.91

7.89

2.3

g/l

0.0

0.54

460

(3005988) Vibrio sp identified in Specimen by Organism specific culture

226

2.38

7.88

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

531

1.88

7.82

1.3

1.2

u/ml

4.0

50.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

227

2.37

7.80

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

398

2.02

7.79

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

217

1461

1.54

7.71

2.2

2.7

g/l

10.5

0.06

198

1345

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2015

19055

1.42

7.70

5.5

4.7

mmol/l

2.7

2.8

1.11

1838

17671

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

229

2.34

7.66

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

229

2.34

7.66

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

397

5128

0.73

7.51

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

491

3856

1.35

7.46

2.7

2.5

e6/l

6.2

6.0

0.11

414

3367

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

1228

1.57

7.43

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

621

1.79

7.43

2.3

2.5

g/l

9.8

10.2

0.58

530

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

611

4956

1.32

7.42

1.7

mmol/l

1.5

1.4

2.15

550

4173

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

165

1055

1.61

7.34

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

493

1.88

7.29

1.3

1.2

u/ml

21.3

10.5

0.39

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

473

1.89

7.22

2.3

g/l

0.0

0.00

433

(3026782) Osmolality of Urine

461

3603

1.35

7.21

3.0

2.7

mosm/kgh2o

543.1

551.3

0.34

382

3070

(3018677) aPTT in Platelet poor plasma by Coagulation assay

374

2829

1.38

7.20

2.0

2.1

30.4

29.8

0.78

363

2742

(3051611) Lipemic interference index of Serum or Plasma

182

2.44

7.02

3.8

3.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

486

1.86

6.97

1.3

1.2

u/ml

5.8

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1479

0.55

6.97

4.9

3.7

mmol/l

1.2

0.14

1274

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1981

18745

1.38

6.95

5.0

4.3

mmol/l

4.6

4.7

3.37

1811

17504

(3020779) Urea [Moles/volume] in Serum or Plasma

233

1631

1.48

6.88

9.8

7.4

mmol/l

10.8

9.6

1.40

211

1555

(3045414) Leukocytes [Presence] in Urine

136

844

1.65

6.84

2.3

1.8

—

(3017732) Neutrophils [#/volume] in Blood

192

1293

1.53

6.83

2.9

3.0

e9/l

4.3

4.1

0.52

133

1037

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

469

1.87

6.77

2.4

2.3

g/l

0.0

0.00

432

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

115

2.81

6.74

1.6

u/l

11.4

7.5

0.28

(3007566) Smooth muscle Ab [Titer] in Serum

510

1.82

6.58

1.3

1.2

titre

78.0

88.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1905

17967

1.33

6.44

4.4

3.8

mmol/l

1.4

1.3

5.85

1723

16588

(46235355) HIV 1 and 2 tests - Meaningful Use set

461

3663

1.32

6.38

2.1

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

289

2.07

6.34

5.4

5.8

umol/l

346.3

363.9

0.46

255

(1002224) Polysomnography panel

129

806

1.64

6.33

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.26

6.28

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.26

6.28

1.7

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

390

3032

1.34

6.26

1.8

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

326

1.99

6.19

1.7

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

212

1488

1.47

6.18

2.5

2.7

e9/l

69.6

71.5

0.31

155

1128

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

286

2122

1.40

6.15

2.3

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.85

6.10

1.3

1.1

u/l

20.7

26.0

0.38

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

311

2344

1.38

6.08

2.4

2.1

—

(3000492) Spirometry study

255

1862

1.41

6.01

1.6

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

289

2.03

5.97

1.5

1.6

g/l

0.7

0.8

0.22

228

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

556

1.74

5.97

1.9

1.7

g/l

0.2

1.16

528

(3028026) IgM [Mass/volume] in Serum or Plasma

171

1158

1.51

5.95

1.5

1.8

g/l

1.3

1.4

0.24

152

1069

(4198724)

3.06

5.92

1.3

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

206

1453

1.46

5.86

2.8

2.7

g/l

67.2

66.4

0.82

182

1337

(3024928) Oxygen saturation in Venous blood

383

1.88

5.83

4.3

3.6

—

(3002032) Base excess in Venous blood by calculation

234

1692

1.43

5.83

4.7

4.0

mmol/l

1.4

1.9

1.53

197

1338

(3027945) Reticulocytes/100 erythrocytes in Blood

273

2029

1.39

5.81

2.6

2.7

1.8

0.04

230

1809

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1960

18630

1.33

5.76

5.0

4.2

mmol/l

1.4

1.5

10.68

1783

17288

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.80

5.73

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.80

5.73

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.80

5.73

1.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.80

5.73

1.6

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

234

1700

1.42

5.68

4.7

4.0

kpa

5.9

0.42

228

1648

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

711

1.63

5.67

1.4

1.2

u/ml

0.4

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

447

3591

1.30

5.66

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.07

5.63

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.44

5.62

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.44

5.62

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.89

5.62

1.8

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.42

5.55

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.01

5.53

1.6

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.01

5.53

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.01

5.53

1.6

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.86

5.51

1.8

1.4

—

(3020491) Glucose [Moles/volume] in Blood

129

2.50

5.45

1.9

2.0

mmol/l

7.1

7.0

0.08

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.35

5.44

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

2.97

5.41

36.3

31.5

ug/l

7.3

0.01

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

301

1.95

5.37

1.5

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

226

2.10

5.35

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

234

2.07

5.28

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.02

5.26

1.3

1.4

umol/l

47.5

49.7

0.07

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

2.38

5.23

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

144

2.38

5.23

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

144

2.38

5.23

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

3.06

5.22

1.7

1.6

—

(4024509)

163

2.29

5.22

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

398

1.81

5.20

1.3

1.2

u/ml

8.3

45.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

124

807

1.57

5.19

2.1

1.9

g/l

1.6

1.5

0.72

111

704

(40768443) Skin Pathology biopsy report

121

785

1.57

5.14

1.2

—

(3021589) Normoblasts [#/volume] in Blood

961

8509

1.22

5.13

9.3

9.2

e9/l

0.0

1.13

745

6971

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

190

1358

1.43

5.06

2.3

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.18

5.04

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

185

2.18

5.04

3.2

3.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.82

4.98

1.6

3.1

umol/l

126.9

114.8

—

(3036489) Thrombin time

113

731

1.57

4.88

1.8

2.2

21.2

21.3

0.17

103

645

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

136

919

1.51

4.83

2.3

—

(3005570) Glucose [Moles/volume] in Urine

202

2.10

4.81

1.7

2.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

169

1195

1.45

4.78

2.1

2.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

387

1.78

4.77

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

512

1.66

4.63

1.8

2.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

543

1.64

4.62

1.1

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

247

1.96

4.60

2.8

1.7

titre

1792.0

1506.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.42

4.56

1.2

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

349

4309

0.78

4.51

4.9

4.5

—

(3045424) Erythrocytes [Presence] in Urine

314

1.84

4.46

1.9

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

565

1.62

4.43

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

156

2.20

4.40

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

176

2.12

4.39

3.1

4.0

—

(3002256) Pathology report gross observation

305

2408

1.31

4.36

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

571

1.60

4.26

1.2

—

(3049717) Cytology report of Urine Cyto stain

106

702

1.53

4.17

2.7

2.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.92

4.17

1.1

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

167

2.11

4.13

3.1

3.3

58.8

54.8

0.35

113

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

601

1.57

4.08

3.0

3.1

u/ml

0.3

0.80

333

(3014051) Protein [Presence] in Urine by Test strip

437

1.67

4.07

2.6

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

594

1.57

4.06

1.7

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

563

1.59

4.04

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

187

1392

1.37

3.98

3.8

3.3

kpa

4.8

4.6

0.56

180

1346

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

149

1068

1.42

3.96

2.2

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

583

1.57

3.92

2.4

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

185

1379

1.37

3.91

2.1

2.2

nmol/l

11.9

12.8

0.61

149

1227

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.61

3.80

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

2.37

3.74

1.3

1.2

u/l

15.0

16.0

0.07

(3039744) RNA polymerase III Ab [Units/volume] in Serum

6.68

3.67

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.68

3.64

4.1

6.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

2.43

3.64

9.8

5.9

u/ml

41.6

40.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

193

1466

1.35

3.63

3.3

2.9

ng/l

179.5

191.2

0.19

168

1329

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

2.15

3.61

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

229

1786

1.31

3.60

3.1

4.2

ug/l

15.5

21.8

0.23

183

1453

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

137

989

1.41

3.53

11.1

10.9

—

(21494755) Public health laboratory ask at order entry panel

140

1900

0.72

3.51

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

567

1.54

3.50

2.2

2.6

g/l

3.9

3.6

0.84

532

(3035637) Corticotropin [Mass/volume] in Plasma

237

1.83

3.44

1.4

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

133

2.12

3.39

1.7

2.5

e6/l

941.4

722.3

0.79

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

115

811

1.44

3.38

1.6

1.9

u/l

38.3

39.0

0.15

721

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.11

3.37

1.0

1.2

ug/l

115.8

102.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.02

3.36

8.6

3.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.72

3.35

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

485

1.56

3.34

1.4

1.3

—

(4035726)

205

1594

1.31

3.30

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

536

1.53

3.27

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

177

1350

1.34

3.27

1.2

iu/ml

160.6

158.3

0.02

516

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.35

3.24

1.0

—

(3022689) Creatine [Moles/volume] in Urine

2.87

3.19

1.5

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

130

2.09

3.18

3.1

2.1

—

(3025941) Bacteria identified in Stool by Culture

144

1069

1.37

3.17

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

281

1.72

3.16

3.5

3.2

1.5

1.4

0.08

226

(3044927) Protein electrophoresis panel - Urine

180

1.90

3.10

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

291

1.70

3.08

1.2

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

222

1764

1.29

3.06

2.4

2.1

nmol/l

395.2

372.6

0.83

202

1627

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

106

2.18

3.03

1.6

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

147

1.99

3.00

1.1

—

80.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

264

1.72

2.96

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

254

2066

1.26

2.90

8.7

8.0

kpa

5.2

5.1

0.82

244

1970

(3027801) Oxygen [Partial pressure] in Arterial blood

254

2067

1.26

2.89

8.7

8.0

kpa

11.6

12.4

1.70

245

1973

(3003396) Base excess in Arterial blood by calculation

253

2058

1.26

2.89

8.7

8.0

mmol/l

0.6

1.0

0.75

204

1604

(4015189)

2.70

2.89

1.5

2.5

—

(3029075) Extractable nuclear Ab panel - Serum

2.60

2.87

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

200

1.81

2.85

1.4

e6/l

2701.3

1716.2

0.48

137

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

384

1.58

2.84

5.1

5.4

iu/ml

422.0

730.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

521

1.49

2.84

1.1

u/ml

24.3

4.7

0.52

(3011412) CD3 cells [#/volume] in Blood

172

1.87

2.81

1.3

2.5

e9/l

1.3

1.2

0.20

102

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

356

0.45

2.78

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

133

998

1.35

2.77

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

347

1.60

2.77

1.2

—

372.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

2.15

2.71

2.0

2.2

ug/min

39.6

146.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

146

1.93

2.70

1.8

2.2

48.6

45.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

335

1.60

2.66

1.0

1.1

u/ml

4.6

4.7

0.02

178

(3000475) Leukocytes [#/volume] in Synovial fluid

447

1.51

2.66

1.4

1.7

e6/l

6524.1

14206.0

1.73

331

(3044290) Cell count panel - Cerebral spinal fluid

407

1.54

2.65

1.1

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.80

2.64

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.80

2.64

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.80

2.64

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.80

2.64

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

409

1.53

2.60

1.5

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

177

1.82

2.60

3.8

4.7

u/ml

45.4

65.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.61

2.57

1.1

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

264

2191

1.23

2.54

5.3

6.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

308

1.60

2.53

1.3

1.2

u/ml

5.5

5.3

0.05

135

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

108

2.05

2.51

1.2

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

520

1.46

2.49

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

174

1.79

2.42

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

515

1.45

2.42

5.2

4.0

mg/l

1.6

1.5

0.24

475

(3032057) Clostridioides difficile [Presence] in Stool

2.95

2.41

1.3

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.42

2.37

1.4

3.1

—

(3019174) dRVVT (LA screen)

3.65

2.36

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

151

1185

1.29

2.34

2.6

3.3

pmol/l

4.4

4.5

0.47

127

1056

(3012441) Differential panel - Pleural fluid

176

1.77

2.34

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

731

0.65

2.32

1.6

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

579

1.41

2.31

1.6

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

112

1.97

2.30

2.0

1.4

nmol/l

1.3

0.02

(3025130) Human papilloma virus identified in Specimen

254

1.63

2.27

2.0

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.23

2.27

1.1

2.3

12.1

9.6

0.57

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.49

2.27

1.3

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

382

1.50

2.26

1.1

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

106

1.99

2.25

4.9

6.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

1.96

2.25

1.2

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

662

6000

1.14

2.25

5.1

4.8

ug/l

2.1

3.0

2.56

580

5387

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

430

0.55

2.24

2.1

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

164

1.78

2.23

3.0

3.3

mg/l

86.3

37.9

0.30

126

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

533

1.42

2.22

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.56

2.21

1.0

1.3

—

(3016879) Cocaine [Presence] in Urine

689

1.36

2.17

1.6

2.1

—

(3051651) Icteric interference index of Serum or Plasma

115

1.92

2.15

4.4

3.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.69

2.15

4.7

5.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

395

1.48

2.15

2.2

3.0

umol/l

34.7

35.4

0.09

337

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.37

2.12

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

323

1.53

2.12

1.0

1.1

u/ml

2.1

1.4

0.18

141

(3000764) Benzodiazepines [Presence] in Urine

744

1.35

2.11

1.6

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.21

2.09

2.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

506

1.42

2.09

1.6

2.1

mg/l

12.0

11.0

0.48

464

(1761482) Bacteria [#/volume] in Urine by Culture

445

0.58

2.08

5.0

4.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

1.77

2.08

1.3

1.2

titre

88.6

203.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

117

1.89

2.06

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

183

1497

1.24

2.05

1.9

2.4

ug/l

6.1

7.4

0.65

146

1346

(3038177) Helicobacter pylori Ab [Presence] in Serum

318

1.52

2.04

1.3

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

145

1156

1.27

2.03

11.9

9.6

93.3

94.0

0.60

145

1149

(3028308) Erythrocytes [#/volume] in Pleural fluid

177

1.70

2.02

1.5

1.4

e6/l

39525.5

78109.9

0.42

102

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

327

1.51

2.01

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

535

1.40

2.01

1.8

1.7

nmol/l

46.2

40.0

1.11

518

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

119

926

1.30

2.01

3.4

3.2

u/ml

100.4

51.0

0.67

112

895

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

398

3505

1.16

2.01

3.4

3.0

ug/l

0.8

0.7

0.06

299

2309

(3021387) Prolactin [Units/volume] in Serum or Plasma

725

1.34

2.00

1.6

1.5

mu/l

333.4

308.7

0.31

653

(3023323) Follitropin [Units/volume] in Serum or Plasma

121

945

1.30

1.99

1.5

1.4

iu/l

22.5

27.8

1.10

102

795

(3009214) Lutropin [Units/volume] in Serum or Plasma

562

1.38

1.99

1.3

1.4

u/l

11.1

9.8

0.38

449

(3028300) Cannabinoids [Presence] in Urine

752

1.33

1.98

1.6

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.29

1.97

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

2.09

1.96

3.6

2.7

—

(3008898) HLA-B27 [Presence]

702

1.34

1.95

1.1

—

(4268621)

210

1.63

1.95

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

363

1.47

1.94

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

290

1.53

1.93

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

380

1.46

1.93

1.9

1.8

pmol/l

174.6

204.9

1.07

361

(3006922) Hepatitis E virus Ab [Presence] in Serum

120

1.84

1.92

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

397

0.58

1.92

3.8

mg/l

26.9

25.4

—

260

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

275

1.54

1.90

1.4

u/l

27.9

26.0

0.14

225

(3027008) Opiates [Presence] in Urine

750

1.32

1.88

1.6

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

3.19

1.88

1.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

166

1.70

1.87

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

166

1.70

1.87

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

166

1.70

1.87

1.6

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

647

1.34

1.86

1.4

1.3

—

(3023410) Appearance of Cerebral spinal fluid

206

1.61

1.83

1.3

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.17

1.82

1.4

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

143

1155

1.25

1.82

12.0

9.6

0.6

0.7

1.63

143

1146

(3038515) Glucose [Moles/volume] in Venous blood

364

0.57

1.80

6.0

3.3

mmol/l

7.5

7.6

0.06

357

(3044889) 12 lead EKG panel

1375

13139

1.11

1.80

3.7

3.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

223

1.58

1.79

2.6

2.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

146

1.72

1.77

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

461

0.62

1.77

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

338

1.46

1.75

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

209

1.59

1.74

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

217

1.58

1.73

1.4

g/l

32.2

32.1

0.01

194

(3002523) Influenza virus A Ag [Presence] in Specimen

339

1.45

1.73

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1666

16109

1.12

1.71

22.3

16.3

13.7

13.6

0.81

1641

15758

(3034274) Bile acid [Moles/volume] in Serum --fasting

250

1.53

1.71

2.4

2.2

umol/l

6.8

7.1

0.06

178

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.96

1.69

2.4

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

369

0.59

1.68

3.3

2.5

16.8

16.3

0.25

190

(3016502) Oxygen saturation in Arterial blood

217

1847

1.19

1.67

9.4

8.4

95.0

95.7

1.08

210

1778

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

375

1.42

1.67

1.1

u/ml

0.7

2.0

1.30

157

(3016018) Differential panel - Cerebral spinal fluid

196

1.59

1.65

1.2

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.10

1.65

2.1

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.25

1.63

1.1

1.2

pmol/l

292.2

310.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

118

946

1.26

1.63

2.6

2.9

e6/l

0.3

0.2

0.28

113

919

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

480

1.36

1.61

1.3

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.58

1.61

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

1.45

1.57

1.1

u/ml

2.9

3.1

0.04

(3042733) HLA Ab [Presence] in Serum

2.11

1.55

6.3

5.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

141

1161

1.23

1.55

12.1

9.5

1.3

1.4

0.11

141

1153

(3051593) INR in Capillary blood by Coagulation assay

1.98

1.54

7.6

14.9

—

(3021788) Differential panel - Synovial fluid

340

1.42

1.53

1.3

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

115

1.75

1.52

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

115

1.75

1.52

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.34

1.52

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

3.34

1.52

1.2

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

324

1.43

1.51

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

123

1.71

1.51

1.4

1.5

u/ml

18.8

21.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.87

1.50

1.3

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

505

1.34

1.48

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

251

1.48

1.2

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

506

1.33

1.47

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

163

1928

0.83

1.46

3.3

3.2

—

(40768795) Lymph node Pathology biopsy report

170

0.47

1.46

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

649

0.72

1.46

1.4

1.5

—

(4094501)

498

1.33

1.45

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

254

0.55

1.45

1.7

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

507

1.33

1.45

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

508

1.33

1.43

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.31

1.43

1.1

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

376

0.63

1.43

3.2

3.6

e9/l

3.7

4.1

0.73

376

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

329

1.41

1.2

1.1

iu/ml

1.7

1642.3

—

(3003338) MCHC [Mass/volume]

1694

16460

1.11

1.40

23.3

17.3

g/l

331.9

332.6

2.54

1682

16337

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

321

1.41

1.40

1.3

1.2

u/ml

2.6

3.4

0.40

114

(4062490)

181

1.55

1.40

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.01

1.38

1.1

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

272

1.44

1.37

1.1

g/l

1.5

0.15

247

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

183

1.54

1.34

1.5

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

175

1.55

1.34

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

1.34

0.0

1.2

—

135.6

—

(3044941) Cell count panel - Synovial fluid

299

1.41

1.33

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.92

1.33

2.4

2.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

136

1.62

1.32

2.3

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

411

1.35

1.31

1.8

1.3

—

12.5

—

(44806071)

2.50

1.30

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.50

1.30

7.0

9.5

mmol/l

4.8

6.2

—

(3027944) Amphetamines [Presence] in Urine

739

1.25

1.30

1.6

2.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.36

1.29

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

1.29

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.36

1.29

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

390

0.66

1.29

4.3

3.9

52.1

57.3

0.99

390

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.78

1.28

2.2

10.7

—

(3010421) pH of Blood

472

0.69

1.28

3.6

4.3

7.4

1.29

387

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

1.64

1.27

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1079

0.80

1.27

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

227

1.46

1.26

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

216

0.55

1.24

5.0

2.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.40

1.24

1.3

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

124

1.62

1.20

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

418

1.32

1.20

1.5

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

109

1.66

1.18

1.2

1.6

ug/l

6.5

9.6

0.74

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

1.66

1.18

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.31

1.18

1.8

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.11

1.18

1.9

2.3

umol/l

21.6

17.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

133

1.58

1.17

1.1

2.2

11.0

14.3

0.96

(3020191) Ethanol [Moles/volume] in Serum or Plasma

149

1.55

1.17

1.3

1.4

promille

1.4

1.2

0.15

121

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

499

1.29

1.17

1.2

1.4

—

(3012501) Base excess in Blood by calculation

392

0.69

1.16

3.6

4.6

mmol/l

2.5

2.6

0.13

264

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

110

1.64

1.15

2.0

2.8

41.3

39.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

110

1.64

1.15

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

174

1.50

1.15

3.2

2.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.15

1.0

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

134

1.57

1.14

1.1

2.3

76.2

72.4

0.77

129

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

635

1.25

1.14

1.3

miu/ml

217.7

228.7

0.10

293

(3052592) Norovirus Ag [Presence] in Stool

2.34

1.12

1.1

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

151

1.53

1.11

1.2

u/ml

1.7

0.7

0.26

(3019832) Treponema pallidum Ab [Presence] in Serum

221

1955

1.14

1.11

1.8

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

243

1.41

1.09

1.1

u/ml

11.3

5.6

0.47

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3008295) Osmolality of Serum or Plasma

185

1.46

1.08

1.2

1.4

mosm/kgh2o

287.1

280.6

0.73

140

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.69

1.07

1.1

1.2

—

(3020891) Body temperature

714

0.78

1.07

4.0

4.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

137

1.54

1.05

2.0

1.4

pmol/l

77.1

265.0

0.44

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.12

1.05

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

121

1.57

1.05

1.5

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

402

1.30

1.04

1.9

1.4

—

(3011985) Renin [Units/volume] in Plasma

229

1.40

1.03

1.6

1.4

mu/l

56.1

44.0

0.18

208

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.96

1.03

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.28

1.03

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.28

1.03

1.6

2.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.28

1.03

2.0

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.28

1.03

1.8

1.5

ng/l

87.6

119.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

122

1.56

1.02

1.0

1.1

nmol/l

0.7

2.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.89

1.01

1.2

1.1

u/ml

5.7

0.8

—

(3023419) Bacteria identified in Sputum by Culture

239

1.39

1.00

2.6

2.7

—

(3006653) Thiamine [Moles/volume] in Blood

107

1.59

0.99

1.4

nmol/l

131.8

138.3

0.24

107

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

803

1.20

0.98

3.7

3.0

0.6

0.7

1.08

775

(3039443) Prostate specific Ag panel - Serum or Plasma

343

0.70

0.98

1.8

1.7

—

(4306422)

301

1.33

0.97

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

124

1.54

0.96

1.1

2.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

532

1.25

0.96

2.1

1.7

—

(3048879) Bone marrow aspiration report

1.80

0.96

1.9

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.96

0.0

6.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

0.52

0.94

1.7

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.23

0.93

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

269

1.34

0.92

1.1

u/ml

10.4

3.9

0.96

100

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

554

1.23

0.91

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

746

1.20

0.91

2.3

2.1

u/l

2832.8

4331.8

0.27

302

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.60

0.90

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.60

0.90

1.5

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

153

0.59

0.88

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

334

0.72

0.87

3.6

3.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

540

1.23

0.86

2.9

3.6

mg/l

25.2

71.4

1.20

433

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

423

1.26

0.86

1.8

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

178

1.41

0.86

1.1

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

308

1.30

0.85

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

669

0.80

0.85

1.3

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

317

1.30

0.85

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

496

1.24

0.85

1.7

1.9

iu/l

4.7

4.8

0.02

176

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

1.45

0.85

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

238

2159

1.11

0.84

1.9

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

222

1.36

0.83

1.1

92.0

96.1

0.36

209

(3006184) Hemoglobin [Mass/volume] in Capillary blood

410

0.75

0.82

2.6

2.2

g/l

132.6

130.5

0.14

303

(3003181) Sodium [Moles/volume] in Urine

293

1.30

0.81

1.6

1.3

mmol/l

59.3

63.2

0.22

245

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

373

1.27

0.81

2.7

3.4

u/ml

41.5

1064.7

0.87

347

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

206

1.36

0.81

1.5

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.70

0.80

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

224

1.34

0.80

1.0

u/ml

3.4

0.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.79

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

0.78

1.3

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.53

0.78

2.1

1.7

—

10.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

630

1.20

0.78

2.7

3.4

u/ml

104.3

6297.6

0.79

531

(3034860) Kappa light chains.free [Mass/volume] in Serum

539

1.21

0.77

2.9

3.6

mg/l

52.1

69.8

0.41

431

(3004716) Salmonella sp identified in Stool by Organism specific culture

121

1059

1.15

0.77

1.4

1.3

—

(3019060) Gas panel - Arterial blood

102

1175

0.86

0.76

4.1

5.4

—

(3022621) pH of Urine by Test strip

138

1222

1.14

0.75

2.6

2.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.84

0.73

1.1

1.5

—

166.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.52

0.72

1.2

iu/ml

185.7

217.6

0.22

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.75

0.71

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.75

0.71

1.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

955

9225

1.06

0.70

3.6

3.5

estimate

0.0

0.00

109

1740

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.71

0.70

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

166

1496

1.12

0.69

3.8

2.5

ml/min/173m2

69.3

68.3

0.13

566

(40761535) Cells panel - Urine sediment

164

1477

1.12

0.69

3.5

3.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

308

0.74

0.69

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

152

1.39

0.69

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.64

0.68

1.9

1.5

pmol/l

14.0

13.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.85

0.68

1.0

1.2

—

(1616796) Gas panel - Central venous blood

385

0.78

0.67

4.2

3.9

—

(40757373) Influenza virus identified in Isolate

1.63

0.66

1.6

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

312

1.25

0.66

1.5

1.4

nmol/l

0.4

0.3

0.65

245

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.53

0.66

1.8

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

179

0.67

0.66

1.2

1.5

16.6

30.4

—

113

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

128

1.41

0.65

1.0

ng/l

776.9

712.8

0.22

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.73

0.64

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

278

1.26

0.64

1.2

1.1

u/ml

7.4

2.2

1.09

129

(21494434) Karyotype in Bone marrow

172

1.34

0.63

1.3

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

129

1.40

0.63

1.0

ng/l

39.4

44.4

0.28

(3005033) Fetal Nuchal fold Thickness US

415

1.21

0.62

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.60

0.61

2.3

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.60

0.61

2.3

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

156

1.35

0.61

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

453

1.20

0.61

2.3

2.4

ug/min

103.6

113.4

0.07

286

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

398

1.21

0.61

1.6

1.3

u/ml

198.2

249.5

1.12

238

(4034850)

608

0.84

0.60

11.6

9.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.60

0.0

1.2

—

704.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.60

0.0

1.1

—

23.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

0.64

0.60

1.7

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

780

1.15

0.60

1.6

1.7

mg/l

3.6

3.8

0.09

547

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.59

0.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

418

1.20

0.59

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.56

0.58

1.0

1.4

—

90.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

586

1.17

0.57

1.6

iu/ml

25.1

11.3

0.21

107

(3045788) Cell count panel - Pleural fluid

158

1.33

0.57

1.7

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

167

1.32

0.56

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.56

2.2

2.8

—

(3025159) Blasts/100 leukocytes in Blood

127

1405

0.90

0.55

5.0

4.1

0.0

0.6

0.95

341

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.54

0.55

1.2

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

305

0.78

0.53

1.4

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.45

0.53

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.52

0.52

1.0

1.1

—

91.7

—

(44806118)

215

0.74

0.52

1.5

—

(44790048)

215

0.74

0.52

1.5

—

(44790047)

215

0.74

0.52

1.5

—

(44790049)

215

0.74

0.52

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

205

1.27

0.52

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.62

0.52

1.2

1.4

—

68.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.62

0.52

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

369

1.20

0.52

1.2

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

950

9240

1.05

0.52

5.1

4.8

estimate

0.0

0.50

120

1778

(3024932) HLA-DR beta [Type]

1.41

0.51

1.2

1.1

—

(3034426) Prothrombin time (PT)

1.41

0.51

1.6

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

109

1.38

0.51

1.0

u/ml

29.7

0.6

—

(3024471) HLA-A [Type]

1.39

0.50

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.46

0.50

2.2

2.9

—

(3017181) Myelocytes/100 leukocytes in Blood

144

1568

0.91

0.48

4.9

4.0

1.0

0.9

0.14

444

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

447

1.17

0.48

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

128

1.33

0.47

1.0

ng/l

294.2

305.6

0.09

(3050129) First trimester maternal screen panel - Serum or Plasma

626

1.14

0.47

1.6

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

430

1.17

0.46

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.59

0.45

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

0.59

0.45

3.6

2.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

852

0.89

0.44

4.3

3.3

mmol/l

24.5

25.3

1.24

822

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

230

0.78

0.43

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

157

1.28

0.43

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

1.35

0.43

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.61

0.43

1.4

1.5

—

(3042631) Mycobacterium sp identified in Specimen

239

1.22

0.42

2.6

—

(4211845)

0.64

0.42

3.2

2.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

203

1.23

0.42

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.7

—

(3001729) Color of Synovial fluid

0.00

0.41

0.0

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.36

0.41

1.1

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

194

0.77

0.40

1.6

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.33

0.40

1.3

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

150

1.27

0.40

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

232

1.21

0.40

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.31

0.39

1.0

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

955

9338

1.04

0.39

3.6

3.5

estimate

0.0

0.37

111

1706

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1.20

0.39

1.3

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.39

0.0

1.0

—

10.0

—

(3011648) Oxygen content in Venous blood

151

1.26

0.38

2.7

4.3

11.0

11.2

0.09

151

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

318

1.17

0.36

1.6

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.27

0.36

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.30

0.35

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

191

1.21

0.33

1.1

1.2

—

(3000012) Reticulocyte production index

0.67

0.32

1.2

1.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

174

1.21

0.31

1.6

2.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

164

0.79

0.30

1.3

2.0

nmol/l

18.8

20.4

0.22

153

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

221

1.18

0.30

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

1.23

0.30

1.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

231

1.17

0.29

1.0

1.1

—

(4027681)

130

0.77

0.29

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.25

0.29

1.0

1.1

—

(3017704) Immunofixation for Urine

106

0.75

0.29

1.0

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.23

0.29

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.26

0.28

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.32

0.28

3.1

4.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

119

0.76

0.27

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

495

4819

1.03

0.27

4.1

4.3

23.1

21.6

1.27

238

2337

(40760888) Immunoglobulin light chains.free panel - Serum

404

1.12

0.27

3.4

3.8

—

(3019150) Specific gravity of Urine by Refractometry

389

4011

0.96

0.26

3.6

3.8

kg/l

1.0

0.46

569

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

966

0.93

0.26

1.4

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

712

1.08

0.26

2.0

ug/l

2.1

1.8

0.14

632

(3021440) Promyelocytes/100 leukocytes in Blood

141

1489

0.94

0.26

4.9

4.1

0.0

0.1

8.87

407

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

320

1.13

0.25

1.3

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

136

1435

0.94

0.25

4.5

3.9

1.3

0.5

0.50

321

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

171

1792

0.95

0.24

1.8

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.18

0.24

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.71

0.24

1.7

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

171

1.17

0.23

1.4

mmol/l

14.3

12.0

0.38

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.28

0.23

1.4

1.0

u/ml

85.6

42.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

18.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.7

—

21.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.5

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

2.1

—

2.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

411

1.10

0.21

3.7

2.2

nmol/l

0.9

0.8

0.11

344

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

357.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

211

1.14

0.20

1.1

1.3

nmol/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

1.20

0.20

1.6

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.20

0.0

1.9

—

0.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.20

1.0

1.1

—

(4133840)

1.13

0.18

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.13

0.18

1.0

1.3

—

(40768441) Liver Pathology biopsy report

143

0.84

0.18

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

242

1.12

0.18

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.19

0.18

1.4

ug/l

7.5

9.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.17

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.76

0.17

1.2

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.13

0.16

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.75

0.15

1.2

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.11

0.15

1.0

1.2

—

0.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.11

0.15

1.4

2.1

ug/l

17.3

119.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.80

0.14

1.0

1.1

miu/ml

1582.9

1652.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

372

1.08

0.14

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

139

0.86

0.14

1.4

1.6

—

(4281824)

189

1.11

0.13

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

100

0.80

0.13

1.4

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

117

1212

0.96

0.13

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

252

0.91

0.12

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.18

0.12

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

152

1.12

0.12

1.5

2.2

u/field

0.6

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

444

1.06

0.11

1.2

1.5

e6/l

18.8

31.6

0.32

348

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

444

1.06

0.11

1.3

1.5

e6/l

112.3

1201.5

1.11

363

(3015235) Bicarbonate [Moles/volume] in Capillary blood

475

1.05

0.10

3.8

3.2

mmol/l

24.7

0.05

413

(21494890) Protein electrophoresis panel - 24 hour Urine

187

0.91

0.10

2.1

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

307

3119

0.98

0.10

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

135

0.89

0.09

1.1

1.2

—

(3045142) Bone marrow Pathology biopsy report

207

0.92

0.09

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

1.11

0.09

1.0

1.1

u/l

0.9

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.03

0.08

10.5

5.9

mmol/l

22.0

25.7

—

(3028433) Virus identified in Specimen by Culture

0.83

0.08

1.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

273

1.06

0.08

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

784

0.97

0.08

4.7

3.8

52.7

48.8

0.62

774

(44813793)

127

1.10

0.08

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

143

0.91

0.07

1.3

1.5

g/l

1.0

0.08

143

(40768793) Breast Pathology biopsy report

412

1.04

0.07

1.4

1.3

—

(3004451) EKG impression Narrative

0.86

0.07

1.1

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

433

1.04

0.06

1.6

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

335

1.05

0.06

3.3

3.0

nmol/l

0.8

0.00

258

(3000330) Specific gravity of Urine by Test strip

910

1.02

0.05

3.5

3.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

151

0.93

0.05

2.8

1.9

mg/l

3.7

4.3

0.22

145

(40768800) Prostate Pathology biopsy report

376

1.04

0.05

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

389

3865

1.01

0.04

1.7

pmol/l

54902365.3

35135563.8

0.20

306

3256

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

119

0.92

0.04

1.2

1.3

—

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

162

1.05

0.02

3.2

3.5

u/ml

30.9

47.4

0.48

162

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

194

1953

0.99

0.02

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

288

0.97

0.02

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

322

1.03

0.01

4.8

3.1

—

(3003694) ABO and Rh group [Type] in Blood

548

5490

1.00

0.01

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

156

0.96

0.00

2.2

656.8

621.9

—

103

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

0.99

0.00

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.02

0.00

1.2

1.1

—

(3035880) pH of Pleural fluid

1.02

0.00

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

108

1.02

0.00

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

342

0.99

0.00

2.0

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

233

0.99

0.00

1.1

1.7

61.8

60.7

0.04

148

(3041806) Other cells [#/volume] in Blood by Manual count

0.93

0.00

1.0

1.6

—

(3024263) Appearance of Synovial fluid

0.92

0.00

1.2

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.90

0.00

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1765.2

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.88

0.00

1.3

1.2

108.7

109.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.98

0.00

1.0

1.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

180

1.00

0.00

1.1

1.4

e6/l

5791.0

113797.5

—

125

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.92

0.00

1.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.88

0.00

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.97

0.00

1.7

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

17.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

17.8

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.92

0.00

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

0.97

0.00

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.97

0.00

1.2

2.6

u/ml

528.8

1249.7

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

382.8

—

(4038314)

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXT_INFNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.229 [1.08, 1.4]	0.001
Birth year	0.996 [0.99, 1.0]	0.402

During the follow-up period (1.1.1998 — 31.12.2019), 922 out of 7274 females with H8_EXT_INFNAS died.

Males

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.296 [1.15, 1.46]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1222 out of 6899 males with H8_EXT_INFNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXT_INFNAS.

N-year risk	Females	Males
1	0.084%	0.247%
5	0.761%	1.604%
10	1.791%	4.07%
15	3.653%	7.977%
20	6.526%	13.166%

Relationships between endpoints

↥

Index endpoint: H8_EXT_INFNAS – Other infective otitis externa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infective otitis externa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints